DeutschNewstral
Article
The Times of India on 2021-08-08 08:07
Study on Covaxin, Covishield mix shows better results, ICMR says
Related news
- Covishield-Covaxin mix offers better shield, says ICMR studyThe Times of India
Better protection with Covishield-Covaxin combination: ICMRThe Hindu- Mixing Covaxin and Covishield is safe and effective: ICMRThe Times of India
- Mix and match of Covishield and Covaxin safe, more effective: ICMR studyThe Times of India
- 'Covishield, Covaxin can protect against Omicron'The Times of India
- Covaxin effective against Delta Plus variant: ICMRThe Times of India
- Covishield, Covaxin granted conditional market nodThe Times of India
- Delta variants lineages reduces Covaxin antibodies, ICMR studyThe Hindu
- Covishield, Covaxin made fewer antibodies against B.1.617 variantThe Hindu
- Coronavirus | More antibodies produced after Covishield than Covaxin, says studyThe Hindu
- Covishield produces more anti-bodies than Covaxin, says studyThe Hindu
- 'Poorly designed': ICMR distances itself from BHU's Covaxin studyThe Times of India
- Scientists seek better access to ICMR dataThe Hindu
- COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR, Serum Institute of IndiaThe Hindu
- Omicron: ICMR recommends two-dose vaccination, is fine with current Covishield gapThe Times of India
- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- Regular market approval granted for Covishield, Covaxin for use in adult populationThe Hindu
- COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe Hindu
- ICMR slams BHU's Covaxin study, says it wasn't part of itThe Times of India
- CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldThe Hindu